4 Things to know about the QuintilesIMS Medicines Use and Spending in the U.S. report
We have seen a deluge of data recently from government actuaries and pharmacy benefit managers showing a dramatic slowdown in medicine spending growth.
We have seen a deluge of data recently from government actuaries and pharmacy benefit managers showing a dramatic slowdown in medicine spending growth.
We have seen a deluge of data recently from government actuaries and pharmacy benefit managers showing a dramatic slowdown in medicine spending growth.
And the QuintilesIMS Medicines Use and Spending in the U.S. — A Review of 2016 and Outlook to 2021 report further supports this data.
Here are four things you should know about the latest QuintilesIMS report:
Discussions about the cost and affordability of medicines are important. Too often, patients struggle to access the medicines they need and we need focus on advancing common sense, practical solutions that bring down health care costs and lower out-of-pocket costs for patients. But, in order to have productive conversations, we need to be using the same set of facts.
Learn more about the cost and value of medicines at phrma.org/cost.